![](/img/cover-not-exists.png)
Cost effectiveness of preemptive therapy versus prophylaxis in a randomized clinical trial for the prevention of CMV disease in seronegative liver transplant recipients with seropositive donors
Singh, Nina, Winston, Drew J, Razonable, Raymund R, Lyon, G Marshall, Silveira, Fernanda P, Wagener, Marilyn M, Limaye, Ajit PJournal:
Clinical Infectious Diseases
DOI:
10.1093/cid/ciaa1051
Date:
July, 2020
File:
PDF, 564 KB
2020